1. Home
  2. OPBK vs KPTI Comparison

OPBK vs KPTI Comparison

Compare OPBK & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OPBK

OP Bancorp

N/A

Current Price

$13.23

Market Cap

185.7M

Sector

Finance

ML Signal

N/A

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

N/A

Current Price

$5.38

Market Cap

172.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPBK
KPTI
Founded
2005
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.7M
172.6M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
OPBK
KPTI
Price
$13.23
$5.38
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$16.50
$17.50
AVG Volume (30 Days)
31.9K
659.3K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
3.85%
N/A
EPS Growth
23.74
N/A
EPS
1.72
N/A
Revenue
$3,204,000.00
$146,067,000.00
Revenue This Year
$16.07
N/A
Revenue Next Year
$11.60
$46.62
P/E Ratio
$7.25
N/A
Revenue Growth
N/A
0.57
52 Week Low
$10.43
$3.51
52 Week High
$15.27
$10.99

Technical Indicators

Market Signals
Indicator
OPBK
KPTI
Relative Strength Index (RSI) 49.60 26.90
Support Level $12.74 $3.95
Resistance Level $13.24 $6.96
Average True Range (ATR) 0.40 0.88
MACD 0.02 -0.36
Stochastic Oscillator 55.09 5.83

Price Performance

Historical Comparison
OPBK
KPTI

About OPBK OP Bancorp

OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: